Buy Biotech When There's Blood On The Street: Pontifax's Ran Nussbaum

Ran Nussbaum, managing partner with The Pontifax Group, doesn't worry too much about overall market volatility. Biotechs, he feels, are somewhat immune to turmoil because their fundamentals are based in real life.